Skip to main content

Lucira Health, Inc.

LHDXDelisted
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652724

Lucira Health, Inc. was delisted in 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Lucira Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Lucira Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Lucira Health, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Narido Richard ClavanoChief Financial Officer77,910Mar 13, 20230
Collins Kevin WalterChief Revenue Officer234,903Mar 13, 20230
Engelson Erik T.President and Chief Executive23,282Mar 13, 20230
Allen Anthony JosephChief Operations Officer136,520Mar 13, 20230
Kashmolah GhaziEx VP & Chief Quality Officer134,075Feb 21, 20230
Boeding ChadOther: CEO of 10% owner1,014,593IndirectDec 16, 20220
EPIQ Capital Group, LLC10% Owner1,014,593IndirectDec 16, 20220
Epq LLC, Lflu PSOther: Less than 10% owner1,014,593IndirectDec 16, 20220
Epq LLC, Lcovd PS10% Owner1,014,593IndirectDec 16, 20220
Epq LLC, Lcovd Safe PSOther: Less than 10% owner1,014,593IndirectDec 16, 20220
Epq LLC, Ltest PSOther: Less than 10% Owner1,014,593IndirectDec 16, 20220
George DanCFO and Treasurer46,011Sep 20, 20220
Mitra DebkishoreChief Technology Officer382,208Sep 6, 20220
Prashar TamannaVice President117,394Jul 12, 20220
Gardiner Sandra A.Director–Jun 3, 20220
Rogers Erica J.Director–Jun 3, 20220
Lamond DavidDirector–Jun 3, 20220
Yen TuffDirector–Jun 3, 20220
Susan LiorDirector, 10% Owner–Jun 3, 20220
Tablak SteveDirector–Jun 3, 20220
McCauley AlisonDirector–Jun 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 13, 2023 (view filing)5:10 PM ETMar 3-710 daysLateNarido Richard ClavanoChief Financial OfficerSSale−29.4K$1.00−$29.4K−27.4%77.9K after5 lots
Mar 13, 2023 (view filing)5:09 PM ETMar 3-710 daysLateCollins Kevin WalterChief Revenue OfficerSSale−111.8K$0.6604−$73.8K−32.3%234.9K after2 lots
Mar 13, 2023 (view filing)Mar 310 daysLateEngelson Erik T.President and Chief ExecutiveSSale−634.7K$1.04−$657.3K−96.5%23.3K after2 lots
Mar 13, 2023 (view filing)Mar 310 daysLateAllen Anthony JosephChief Operations OfficerSSale−8.40K$1.00−$8.40K−5.8%136.5K after
Feb 21, 2023 (view filing)12:38 PM ETFeb 165 daysKashmolah GhaziEx VP & Chief Quality OfficerSSale−5.03K$0.27−$1.36K−3.6%134.1K after
Dec 22, 2022 (view filing)2:24 PM ETDec 202 daysAllen Anthony JosephChief Operations OfficerSSale−4.26K$0.16−$682.08−2.9%144.9K after
Dec 9, 2022 (view filing)4:24 PM ETNov 2118 daysLateAllen Anthony JosephChief Operations OfficerSSale−34.4K$0.33−$11.4K−18.8%149.2K after2 lots
Dec 9, 2022 (view filing)4:17 PM ETNov 2811 daysLateKashmolah GhaziEx VP & Chief Quality OfficerSSale−7.54K$0.42−$3.17K−5.1%139.1K after
Dec 9, 2022 (view filing)4:15 PM ETNov 1722 daysLateKashmolah GhaziEx VP & Chief Quality OfficerSSale−33.2K$0.3724−$12.4K−18.5%146.6K after2 lots
Dec 6, 2022 (view filing)4:21 PM ETDec 15 daysLateNarido Richard ClavanoInterim CFOSSale−1.58K$0.36−$569.88−1.5%107.3K after
Nov 29, 2022 (view filing)12:08 PM ETNov 272 daysCollins Kevin WalterChief Revenue OfficerSSale−9.67K$0.42−$4.06K−2.7%346.7K after
Nov 18, 2022 (view filing)8:05 PM ETNov 162 daysKashmolah GhaziEx VP & Chief Quality OfficerSSale−4.79K$0.35−$1.68K−2.6%179.9K after
Sep 22, 2022 (view filing)Sep 202 daysAllen Anthony JosephChief Operations OfficerSSale−17.1K$1.39−$23.7K−8.5%183.6K after
Sep 20, 2022 (view filing)Sep 182 daysGeorge DanCFO and TreasurerSSale−343$1.38−$473.34−0.7%46.0K after
Sep 19, 2022 (view filing)Sep 154 daysEngelson Erik T.President and Chief ExecutivePPurchase+20.0K$1.82+$36.4K+31.6%83.3K after
Sep 6, 2022 (view filing)Sep 15 daysMitra DebkishoreChief Technology OfficerSSale−191$1.69−$322.790.0%382.2K after
Aug 29, 2022 (view filing)Aug 272 daysCollins Kevin WalterChief Revenue OfficerSSale−8.58K$1.72−$14.8K−2.4%356.4K after
Aug 29, 2022 (view filing)Aug 254 daysKashmolah GhaziEx VP & Chief Quality OfficerSSale−1.50K$1.93−$2.90K−0.8%184.7K after
Aug 24, 2022 (view filing)Aug 177 daysKashmolah GhaziEx VP & Chief Quality OfficerSSale−19.1K$2.52−$48.1K−9.5%180.8K afterAmended
Aug 19, 2022 (view filing)Aug 181 dayKashmolah GhaziEx VP & Chief Quality OfficerSSale−3.50K$2.25−$7.88K−1.9%177.3K afterAmended
Jul 12, 2022 (view filing)Mar 1-Jun 1133 daysLateMitra DebkishoreChief Technology OfficerSSale−1.08K$4.19−$4.51K−0.3%382.4K after2 lots
Jul 12, 2022 (view filing)Mar 1-Jul 8133 daysLatePrashar TamannaVice PresidentSSale−1.79K$3.98−$7.13K−1.5%117.4K after3 lots
Jul 12, 2022 (view filing)May 2746 daysLateCollins Kevin WalterChief Revenue OfficerSSale−37.1K$2.00−$74.2K−9.2%365.0K after
Jul 12, 2022 (view filing)Jun 1824 daysLateGeorge DanCFO and TreasurerSSale−1.32K$1.45−$1.92K−2.8%46.4K after
Jun 17, 2022 (view filing)Jun 161 dayEngelson Erik T.President and Chief ExecutivePPurchase+10.0K$1.49+$14.9K+18.8%63.3K after
Mar 16, 2022 (view filing)Mar 151 dayEngelson Erik T.President and Chief ExecutivePPurchase+30.0K$3.00+$90.0K+128.9%53.3K after